HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $623,980 | -5.0% | 605,806 | +7.0% | 0.00% | – |
| Q2 2023 | $656,634 | +7.6% | 566,064 | +40.0% | 0.00% | – |
| Q1 2023 | $610,506 | -78.8% | 404,309 | -64.9% | 0.00% | -100.0% |
| Q4 2022 | $2,882,378 | -70.3% | 1,152,951 | -49.9% | 0.00% | -50.0% |
| Q3 2022 | $9,702,000 | +172.8% | 2,299,053 | +80.4% | 0.00% | +100.0% |
| Q2 2022 | $3,556,000 | -72.7% | 1,274,699 | -44.1% | 0.00% | -66.7% |
| Q1 2022 | $13,039,000 | -25.6% | 2,279,598 | +18.8% | 0.00% | 0.0% |
| Q4 2021 | $17,515,000 | +2.3% | 1,918,410 | +19.8% | 0.00% | -25.0% |
| Q3 2021 | $17,125,000 | +59.2% | 1,601,856 | +131.2% | 0.00% | +100.0% |
| Q2 2021 | $10,755,000 | -45.9% | 692,966 | -43.4% | 0.00% | -60.0% |
| Q1 2021 | $19,862,000 | -18.2% | 1,225,285 | +6.7% | 0.01% | -16.7% |
| Q4 2020 | $24,296,000 | +58.7% | 1,147,942 | +11.1% | 0.01% | +50.0% |
| Q3 2020 | $15,309,000 | -12.3% | 1,032,984 | -13.0% | 0.00% | -20.0% |
| Q2 2020 | $17,460,000 | +0.1% | 1,186,955 | -20.1% | 0.01% | -16.7% |
| Q1 2020 | $17,440,000 | -51.7% | 1,485,527 | -3.4% | 0.01% | -33.3% |
| Q4 2019 | $36,134,000 | +183.0% | 1,537,619 | +122.8% | 0.01% | +125.0% |
| Q3 2019 | $12,766,000 | -24.3% | 690,041 | -24.0% | 0.00% | -20.0% |
| Q2 2019 | $16,869,000 | -12.7% | 907,411 | +14.7% | 0.01% | -16.7% |
| Q1 2019 | $19,333,000 | +7.0% | 791,071 | +13.6% | 0.01% | 0.0% |
| Q4 2018 | $18,064,000 | +5.0% | 696,406 | +28.2% | 0.01% | +50.0% |
| Q3 2018 | $17,196,000 | -7.8% | 543,320 | +13.2% | 0.00% | -20.0% |
| Q2 2018 | $18,649,000 | +116.3% | 480,027 | +53.6% | 0.01% | +150.0% |
| Q1 2018 | $8,623,000 | +156.0% | 312,432 | +67.9% | 0.00% | +100.0% |
| Q4 2017 | $3,368,000 | -33.6% | 186,072 | -40.7% | 0.00% | 0.0% |
| Q3 2017 | $5,070,000 | -12.8% | 313,903 | -25.3% | 0.00% | 0.0% |
| Q2 2017 | $5,817,000 | +69.8% | 419,980 | +83.9% | 0.00% | 0.0% |
| Q1 2017 | $3,425,000 | +823.2% | 228,318 | +706.4% | 0.00% | – |
| Q4 2016 | $371,000 | -50.5% | 28,314 | -34.8% | 0.00% | – |
| Q3 2016 | $749,000 | +137.0% | 43,417 | +147.9% | 0.00% | – |
| Q2 2016 | $316,000 | -93.6% | 17,513 | -93.3% | 0.00% | -100.0% |
| Q1 2016 | $4,969,000 | +193.8% | 261,671 | +313.3% | 0.00% | – |
| Q4 2015 | $1,691,000 | -96.9% | 63,317 | -97.2% | 0.00% | -100.0% |
| Q3 2015 | $54,877,000 | +11428.8% | 2,249,039 | +14627.5% | 0.02% | – |
| Q2 2015 | $476,000 | -3.4% | 15,271 | -61.8% | 0.00% | – |
| Q2 2014 | $493,000 | +110.7% | 39,986 | +138.0% | 0.00% | – |
| Q1 2014 | $234,000 | – | 16,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |